Physician
Mary Hitchcock Memorial Hospital
Mary Hitchcock Memorial Hospital was paid $3.75M by Medicaid between Jun 2023 and Dec 2024, across 212 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoMARY HITCHCOCK MEMORIAL HOSPITAL
LEBANON, NH 03756
LEBANON, NH 03756
33aNPI1629788237assigned 12/05/2022
33bProvider typeInternal Medicine Physician
28Total paid$3.75M
24GClaims143,991
24DCodes billed212
24AFirst – last monthJun 2023 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New Hampshire
Rank by total paid#4 of 34
Median peer was paid$13K
This provider vs. median281×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 43,749 | $1.23M | |
| 2024incomplete | 100,242 | $2.52M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 29,405 | 27,129 | $1.62M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 19,089 | 17,875 | $748K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.8% | 2,433 | 2,286 | $143K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 1,927 | 1,888 | $129K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.8% | 1,575 | 1,544 | $103K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.1% | 888 | 867 | $80K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.9% | 1,076 | 1,043 | $73K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.9% | 709 | 399 | $70K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.5% | 471 | 392 | $55K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 9,221 | 8,955 | $49K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 14,057 | 11,326 | $44K |
| 74018 | <1% | 1,828 | 1,728 | $29K |
200 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 519 | $29K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,770 | $28K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 231 | $27K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 665 | $25K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,728 | $24K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 355 | $24K |
| 99205 | Prolong outpt/office vis | <1% | 246 | $19K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 155 | $19K |
| 99245 | <1% | 154 | $19K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 474 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 200 | $17K |
| 99284 | Emergency room visit (serious) | <1% | 241 | $17K |
| 99285 | Emergency room visit (most serious) | <1% | 232 | $17K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 471 | $17K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 238 | $17K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,089 | $16K |
| 76830 | Ultrasound, transvaginal | <1% | 302 | $15K |
| 93000 | <1% | 933 | $14K | |
| 92567 | <1% | 1,742 | $13K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 689 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 600 | $13K |
| 93325 | <1% | 358 | $11K | |
| 76770 | <1% | 210 | $11K | |
| 92558 | <1% | 614 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 231 | $8K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 351 | $8K |
| 93320 | <1% | 154 | $8K | |
| 99243 | <1% | 98 | $8K | |
| 92579 | <1% | 437 | $8K | |
| 64615 | <1% | 127 | $6K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 271 | $5K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 90 | $5K |
| 90837 | Psychotherapy session, about an hour | <1% | 52 | $5K |
| 94010 | <1% | 292 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 90 | $5K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 907 | $5K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 87 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,382 | $4K |
| 99173 | <1% | 524 | $3K | |
| 90686 | <1% | 2,291 | $3K | |
| 20610 | <1% | 216 | $3K | |
| 95117 | <1% | 266 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 160 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 81 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 327 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 25 | $2K |
| 92557 | <1% | 125 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 278 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 206 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,768 | $2K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 467 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 2,269 | $2K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 203 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 792 | $2K |
| 51741 | <1% | 140 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 180 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 50 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 422 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 135 | $2K |
| 51798 | <1% | 139 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 769 | $2K |
| 99177 | <1% | 105 | $2K | |
| 87631 | <1% | 36 | $2K | |
| 97802 | <1% | 24 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 33 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 781 | $1K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 237 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,060 | $1K |
| 81002 | <1% | 798 | $1K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 26 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $1K |
| 90656 | <1% | 1,335 | $1K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 14 | $1K |
| 92587 | <1% | 35 | $974.31 | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 13 | $953.40 |
| D7240 | Removal of impacted tooth - completely bony | <1% | 115 | $902.26 |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 14 | $893.92 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 31 | $874.81 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 27 | $838.35 |
| 91322 | <1% | 96 | $807.61 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 414 | $755.53 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 910 | $657.21 |
| J2704 | Injection, propofol, 10 mg | <1% | 383 | $643.84 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,015 | $633.16 |
| 80061 | Lipid panel | <1% | 696 | $596.21 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 120 | $579.69 |
| 99242 | <1% | 16 | $566.06 | |
| 82728 | <1% | 457 | $526.50 | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 34 | $508.66 |
| 76376 | <1% | 13 | $504.08 | |
| 73030 | <1% | 55 | $474.87 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17 | $474.46 |
| 95251 | <1% | 41 | $466.96 | |
| 59025 | Fetal non-stress test | <1% | 18 | $466.65 |
| 83655 | <1% | 42 | $457.08 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 13 | $423.84 |
| 83735 | <1% | 363 | $384.65 | |
| 97803 | <1% | 12 | $383.96 | |
| 87077 | <1% | 277 | $362.79 | |
| 73630 | <1% | 15 | $356.14 | |
| 73564 | <1% | 31 | $336.10 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 59 | $314.62 |
| 82570 | <1% | 276 | $314.47 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 60 | $294.12 |
| 90474 | <1% | 89 | $291.54 | |
| 84439 | <1% | 321 | $286.97 | |
| 90677 | <1% | 517 | $245.76 | |
| 82607 | <1% | 375 | $239.61 | |
| 71250 | <1% | 13 | $215.82 | |
| 17110 | <1% | 12 | $215.52 | |
| 64405 | <1% | 15 | $215.42 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 409 | $209.32 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 37 | $208.68 |
| 83970 | <1% | 126 | $187.84 | |
| 84100 | <1% | 246 | $180.59 | |
| 82746 | <1% | 124 | $179.79 | |
| 86140 | <1% | 318 | $172.34 | |
| 86850 | <1% | 58 | $170.18 | |
| 83880 | <1% | 42 | $166.94 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 124 | $166.30 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 28 | $162.86 |
| 85027 | <1% | 210 | $146.16 | |
| 90480 | <1% | 111 | $145.95 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 28 | $144.74 |
| 83550 | <1% | 398 | $141.05 | |
| 87070 | <1% | 105 | $129.73 | |
| 81001 | <1% | 327 | $127.16 | |
| 83615 | <1% | 136 | $119.28 | |
| 82962 | <1% | 386 | $118.72 | |
| 82784 | <1% | 117 | $117.21 | |
| 83540 | <1% | 400 | $109.99 | |
| 92552 | <1% | 13 | $109.98 | |
| 85610 | <1% | 325 | $109.67 | |
| 80076 | <1% | 161 | $106.27 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 771 | $104.32 |
| 83690 | <1% | 109 | $97.20 | |
| 82043 | <1% | 183 | $90.48 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $80.12 |
| 96040 | <1% | 207 | $72.48 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 338 | $71.67 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 530 | $70.63 |
| 82040 | <1% | 112 | $62.82 | |
| 92555 | <1% | 12 | $62.04 | |
| 87186 | <1% | 132 | $61.57 | |
| 85652 | <1% | 277 | $58.23 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 396 | $51.78 |
| 86901 | <1% | 69 | $50.40 | |
| 86900 | <1% | 69 | $50.40 | |
| 82248 | <1% | 67 | $50.05 | |
| 96161 | <1% | 65 | $48.44 | |
| 82565 | <1% | 96 | $42.13 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 13 | $38.39 |
| 84484 | <1% | 46 | $37.04 | |
| 81003 | <1% | 192 | $35.28 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $33.62 |
| 85018 | <1% | 14 | $29.64 | |
| 84550 | <1% | 64 | $27.49 | |
| 11721 | <1% | 13 | $26.74 | |
| 88342 | <1% | 32 | $20.54 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 138 | $18.82 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 312 | $16.19 |
| 84460 | <1% | 12 | $13.67 | |
| 84450 | <1% | 12 | $13.36 | |
| 85730 | <1% | 14 | $11.28 | |
| 84156 | <1% | 28 | $10.14 | |
| 36591 | <1% | 31 | $9.91 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 31 | $9.00 |
| 87205 | <1% | 27 | $8.04 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 64 | $7.30 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 331 | $6.89 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 79 | $2.92 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 196 | $1.96 |
| 73502 | <1% | 41 | $1.51 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 12 | $0.76 |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,907 | $0.00 |
| 86364 | 0% | 15 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 549 | $0.00 |
| 90680 | 0% | 90 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 67 | $0.00 |
| 90694 | 0% | 67 | $0.00 | |
| 90697 | 0% | 258 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 57 | $0.00 |
| C1769 | Guide wire | 0% | 16 | $0.00 |
| 90619 | 0% | 12 | $0.00 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 0% | 16 | $0.00 |
| 88341 | 0% | 13 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 0% | 12 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 17 | $0.00 |
| 73610 | 0% | 13 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 191 | $0.00 |
| 90670 | 0% | 74 | $0.00 | |
| 95874 | 0% | 77 | $0.00 | |
| 72100 | 0% | 13 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 202 | $0.00 |
| 80164 | 0% | 12 | $0.00 | |
| 84165 | 0% | 12 | $0.00 | |
| 90653 | 0% | 93 | $0.00 | |
| 90633 | 0% | 12 | $0.00 | |
| 90681 | 0% | 26 | $0.00 | |
| 69210 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFIELDING, WENDY (CHIEF FINANCIAL OFFICER)
Parent organizationMARY HITCHCOCK MEMORIAL HOSPITAL